Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 27 Sep 2017 Planned End Date changed from 1 Sep 2017 to 31 Oct 2017.
- 27 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2017 Planned End Date changed from 1 Aug 2017 to 1 Sep 2017.